Document is current
Any future updates will be listed below
-
Authors
Puckelwartz, Megan J. https://orcid.org/0000-0002-0455-2983
Pesce, Lorenzo L.
Hernandez, Edgar J.
Webster, Gregory
Dellefave-Castillo, Lisa M.
Russell, Mark W.
Geisler, Sarah S.
Kearns, Samuel D.
Karthik, Felix
Etheridge, Susan P.
Monroe, Tanner O.
Pottinger, Tess D.
Kannankeril, Prince J.
Shoemaker, M. Benjamin
Fountain, Darlene
Roden, Dan M.
Faulkner, Meghan
MacLeod, Heather M.
Burns, Kristin M.
Yandell, Mark
Tristani-Firouzi, Martin
George, Alfred L. Jr.
McNally, Elizabeth M.
-
Funding
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (U01HL131914, U01HL131698, HL128075, U01HL131911)
American Heart Association
- License Information
-
More Information
Article History
Received: 22 February 2023
Accepted: 3 January 2024
First Online: 16 January 2024
Declarations
:
: We attest that data included in this manuscript was conducted in a manner consistent with principles of research ethics per the standards of the Belmont Report. Written informed consent was obtained from the parent/guardian of the decedent. This research conformed to the Declaration of Helsinki. Registry activities involving biospecimen collection and consent of surviving family members for research were approved by the institutional review boards at the Data Coordinating Center and participating states/jurisdictions.
: NA
: MY serves as consultant to Fabric Genomics Inc. and has received consulting fees and stock grants from Fabric Genomics Inc. EMM is a consultant for Amgen, Avidity, AstraZeneca, Cytokinetics, PepGen, Pfizer, Tenaya Therapeutics, Stealth BioTherapeutics, and Invitae and is the founder of Ikaika Therapeutics. The remaining authors declare that they do not have any competing interests.
